Evaluation of Drug-Drug Interactions Between the Fixed-Dose Combination of Daclatasvir/Asunaprevir/Beclabuvir and Methadone or Buprenorphine/Naloxone

Conference Reports for NaTaP

EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria april 22-26


Evaluation of Drug-Drug Interactions Between the Fixed-Dose Combination of Daclatasvir/Asunaprevir/Beclabuvir and Methadone or Buprenorphine/Naloxone

	Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria Tao X,1 Sims K,1 Hesney M,1 Lubin S,1 Stonier M,1 Wind-Rotolo M,1 Reynolds L,2 Liang D,2 Pursley J,1 AbuTarif M1 1Bristol-Myers Squibb, Princeton, NJ, USA; 2ICON Development Solutions, Hanover, MD, USA